Request Demo
Last update 05 Jan 2026
DWP-17061
Last update 05 Jan 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Aneratrigine, DWP 17061, DWP-17061 + [2] |
Target |
Action blockers |
Mechanism Nav1.7 blockers(Sodium channel protein type IX alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC19H20ClF2N5O2S2 |
InChIKeyQQPQCLIQRLPULJ-UHFFFAOYSA-N |
CAS Registry2097163-74-9 |
Related
4
Clinical Trials associated with DWP-17061KCT0010415
A phase 0 study to investigate the systemic, trigeminal neuralgia and dorsal root ganglia distribution of iN1011-N17 after intravenous administration of [18F]iN1011-N17 at microdose using whole-body PET scan in healthy male volunteers
NCT06218784
A Randomized, Double-blind, Placebo-controlled, Multiple-Ascending Dose Phase 1b Study to Evaluate the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Properties of iN1011-N17 After Oral Administration in Healthy Volunteers and Post-Herpetic Neuralgia Patients and to Assess the Relative Bioavailability of Mesylate vs Hydrochloride Salt Capsules in Healthy Volunteers
ACTRN12620001253998
A randomized, double-blind, placebo-controlled, single-ascending dose Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics/pharmacodynamics properties of iN1011N17 after oral administration in healthy volunteers
100 Clinical Results associated with DWP-17061
Login to view more data
100 Translational Medicine associated with DWP-17061
Login to view more data
100 Patents (Medical) associated with DWP-17061
Login to view more data
100 Deals associated with DWP-17061
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Arthritis Pain | Phase 1 | South Korea | 26 Apr 2023 | |
| Chronic Pain | Phase 1 | Australia | 30 Sep 2020 | |
| Neuralgia, Postherpetic | Phase 1 | Australia | 30 Sep 2020 | |
| Osteoarthritis | Phase 1 | Australia | 30 Sep 2020 | |
| Musculoskeletal Pain | Phase 1 | Australia | 29 Sep 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free